Crossmark

Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

Crossref DOI link: https://doi.org/10.1007/s10637-022-01226-6

Published Online: 2022-02-28

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Waqar, Saiama N. https://orcid.org/0000-0002-7069-5456
Robinson, Clifford https://orcid.org/0000-0002-1399-9904
Olszanski, Anthony J. https://orcid.org/0000-0001-5276-5898
Spira, Alexander https://orcid.org/0000-0003-1303-0447
Hackmaster, Melissa

Lucas, Luisa

Sponton, Laura

Jin, Hulin

Hering, Ursula

Cronier, Damien

Grinberg, Marianna

Seithel-Keuth, Annick https://orcid.org/0000-0002-4587-5797
Diaz-Padilla, Ivan

Berlin, Jordan https://orcid.org/0000-0001-7571-2385
License Information

Text and Data Mining valid from 2022-02-28

Version of Record valid from 2022-02-28
More Information

Article History

First Online: 28 February 2022